COGNITIVE / DIRECT CATALOG PRICING
N-Acetyl Semax
N-Acetyl Semax (Ac-Semax) is the N-terminally acetylated derivative of the heptapeptide Semax, whose parent sequence is Met-Glu-His-Phe-Pro-Gly-Pro.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Cognitive
- 25 mgPricing by inquiry · AvailableSelect
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
N-Acetyl Semax (Ac-Semax) is the N-terminally acetylated derivative of the heptapeptide Semax, whose parent sequence is Met-Glu-His-Phe-Pro-Gly-Pro.
The cognitive classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Cognitive
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
N-Acetyl Semax (Ac-Semax) is the N-terminally acetylated derivative of the heptapeptide Semax, whose parent sequence is Met-Glu-His-Phe-Pro-Gly-Pro.
- Research covered
- A chemical and laboratory study directly compared Semax and N-terminally acetylated Semax, examining copper and zinc coordination and related in-vitro biological properties.
- Important limit
- The exact acetylated derivative has laboratory chemistry evidence, but the parent Semax clinical literature cannot be assumed to apply to Ac-Semax. No robust human-outcome evidence for the exact derivative was identified, and catalog material requires analytical identity confirmation.
- Authoritative sources
FACTUAL FAQ
N-Acetyl Semax catalog questions
What formats are currently listed?
25 mg. Current price and stock state appear above.
What did researchers study?
A chemical and laboratory study directly compared Semax and N-terminally acetylated Semax, examining copper and zinc coordination and related in-vitro biological properties.
What is the most important evidence limit?
The exact acetylated derivative has laboratory chemistry evidence, but the parent Semax clinical literature cannot be assumed to apply to Ac-Semax. No robust human-outcome evidence for the exact derivative was identified, and catalog material requires analytical identity confirmation.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
